Zafgen is a biopharmaceutical company dedicated to significantly improving the
health and well-being of patients affected by metabolic diseases including type 2 diabetes and obesity.
Mar 09, 2017
Mar 02, 2017
Feb 28, 2017
Feb 09, 2017
We're looking at — and targeting — metabolic diseases in a totally different way
A steady flow of new scientific evidence continues to reveal insights into the breadth of benefits that can be derived from targeting MetAP2, Zafgen’s focus for new therapeutic development.
Learn More »